The first-of-its-kind premier membership program for ASCs to affordably adopt the latest technology solutions for efficiency and patient care NASHVILLE, Tenn.--(BUSINESS WIRE)--HST Pathways, the ...
SAN DIEGO, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), today announced preliminary week 18 results from its Phase 1b/2a clinical trial of HST-001 in male patients with androgenic ...
Planning Underway for Next Clinical Study in U.S. SAN DIEGO, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO) today announced week 26 results from its Phase 1b/2a clinical trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results